Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

Published:2022-09 Issue:9 Volume:25 Page:104949
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Sen Partho,Govaere Olivier,Sinioja Tim,McGlinchey Aidan,Geng Dawei,Ratziu Vlad,Bugianesi Elisabetta,Schattenberg Jörn M.,Vidal-Puig Antonio,Allison Michael,Cockell Simon,Daly Ann K.,Hyötyläinen Tuulia,Anstee Quentin M.,Orešič Matej^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference67 articles.

1. A protein-truncating HSD17B13 variant and protection from chronic liver disease;Abul-Husn;N. Engl. J. Med.,2018

2. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT;Agren;PLoS Comput. Biol.,2012

3. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort;Anstee;J. Hepatol.,2020

4. From NASH to HCC: current concepts and future challenges;Anstee;Nat. Rev. Gastroenterol. Hepatol.,2019

5. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat. Rev. Gastroenterol. Hepatol.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized metabolic whole-body models for newborns and infants predict growth and biomarkers of inherited metabolic diseases;Cell Metabolism;2024-08

2. Lipid Metabolism in MASLD and MASH: from mechanism to the clinic;JHEP Reports;2024-08

3. Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies;Current Opinion in Biomedical Engineering;2024-06

4. Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human;Communications Medicine;2024-03-05

5. A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-03